03 SEP 2010 05:51 MMYEL ACCRUAL REPORT - OPEN and recently closed STUDIES
REGS. REGS. REGS. REGS. REGS.
R LAST LAST LAST LAST LAST # of # of
E ACCR. TOTAL 12 6 3 30 7 ACT. CURR
STUDY G ARM GOAL REGS. Month Month Month DAYS DAYS INSTs IRBs
-------------------------------------- - --------------------------------- ----- ----- ----- ----- ----- ----- ----- ----- -----
S0115-Mel+PBSCT for High Risk MM+ALA 1 1 Induction/PBSCC 110 39 1 0 0 0 0 74 19
2 PBSCC 64 3 2 2 0 0
----- ----- ----- ----- ----- -----
103 4 2 2 0 0
2 3 Autologous Transplants 100 72 4 3 1 0 0 74 19
----- ----- ----- ----- ----- -----
72 4 3 1 0 0
3 4 Dex/Thal 100 13 3 2 0 0 0 74 19
----- ----- ----- ----- ----- -----
13 3 2 0 0 0
S0120-Asympt Monoclonal Gammopathies 1 1 Observation only 385 330 87 46 26 7 3 58 22
----- ----- ----- ----- ----- -----
330 87 46 26 7 3
S0204-Thal/Dex/Pred Tandem PBSCT 1 1 Induction/PBSC Mobilization 99 147 0 0 0 0 0 5 2
----- ----- ----- ----- ----- -----
147 0 0 0 0 0
2 2 Autologous PBSCT 99 108 0 0 0 0 0 5 2
----- ----- ----- ----- ----- -----
108 0 0 0 0 0
3 3 Prednisone + Thalidomide 99 80 0 0 0 0 0 5 2
----- ----- ----- ----- ----- -----
80 0 0 0 0 0
S0232-MM, Frontline, DEX +/- CC-5013 1 1 Blinded Drug 500 100 0 0 0 0 0 82 20
2 Blinded Drug 98 0 0 0 0 0
----- ----- ----- ----- ----- -----
198 0 0 0 0 0
2 3 Crossover Therapy 500 42 0 0 0 0 0 82 20
----- ----- ----- ----- ----- -----
42 0 0 0 0 0
S0309-MMYEL Specimen Repository 1 1 BM and periph blood collection 189 5 3 2 0 0 230 79
----- ----- ----- ----- ----- -----
189 5 3 2 0 0
S0777-MM, Len Dex +/- Bortezomib 1 1 Lenalidomide/Dex 484 111 61 35 23 8 3 207 74
2 Bortezomib/Lenalidomide/Dex 107 60 32 18 7 1
----- ----- ----- ----- ----- -----
218 121 67 41 15 4
2 3 Autologous Transplant 440 1 1 0 0 0 0 207 74
----- ----- ----- ----- ----- -----
1 1 0 0 0 0
15 rows selected.
03 SEP 2010 05:51 MMYEL Open Studies with No Registrations
Study Registration/Phase Open Date
---------------------------------------- ----------------------------------- ---------
CTN0702 Single v Tandem Autol transplant 1 Endorsed Study 09-Jun-10
1 row selected.
no rows selected
03 SEP 2010 05:51 page 1
MMYEL SEGMENT ACCRUAL REPORT - OPEN and recently closed STUDIES
R
E TOTAL
STUDY G ARM SEGMENT REGS.
-------------------------------------- - --------------------------------- ----------------------------------- -----
S0115-Mel+PBSCT for High Risk MM+ALA 1 1 Induction/PBSCC 01: Dex + Thal 39
1 Induction/PBSCC 02: PBSC Mobilization 21
2 PBSCC 02: PBSC Mobilization 64
2 3 Autologous Transplants 03: First PBSC Transplant 72
3 Autologous Transplants 04: Second PBSC Transplant 42
S0204-Thal/Dex/Pred Tandem PBSCT 1 1 Induction/PBSC Mobilization 01: Induction 147
1 Induction/PBSC Mobilization 02: PBSC Mobilization 112
2 2 Autologous PBSCT 03: Transplant 1 108
2 Autologous PBSCT 04: Transplant 2 91
S0232-MM, Frontline, DEX +/- CC-5013 1 1 Blinded Drug 01: Blinded Induction (Arm 1) 100
1 Blinded Drug 02: Blinded Maintenance (Arm 1) 77
1 Blinded Drug 03: Open Label ImiD+Low Dose Dex 48
2 Blinded Drug 01: Blinded Induction (Arm 2) 98
2 Blinded Drug 02: Bilnded Maintenance (Arm 2) 59
2 Blinded Drug 03: Open Label ImiD+Low Dose Dex 23
2 3 Crossover Therapy 01: Un-blinded Induction 40
3 Crossover Therapy 02: Un-blinded Maintenance 25
3 Crossover Therapy 03: Open Label ImiD+Low Dose Dex 18
S0777-MM, Len Dex +/- Bortezomib 1 1 Lenalidomide/Dex 01: Lenalidomide/Dex Induction 110
1 Lenalidomide/Dex 02: Maintenance 11
2 Bortezomib/Lenalidomide/Dex 01: Bort.Lenalidomide/Dex Ind 107
2 Bortezomib/Lenalidomide/Dex 02: Maintenance 12
22 rows selected.
SWOG StatCtr Home Page
1 row selected.